MIRM(Mirum Pharmaceuticals, Inc.) · 财务报表

MIRM(Mirum Pharmaceuticals, Inc.) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$19.14M$77.06M$186.37M$336.89M$521.31M
毛利润—————
营业利润−$173.41M−$131.22M−$109.15M−$87.61M−$22.14M
净利润−$83.99M−$135.66M−$163.41M−$87.94M−$23.36M
经营现金流−$132.76M−$120.14M−$70.94M$10.32M$55.83M
自由现金流−$132.78M−$120.41M−$71.05M$9.33M$54.87M
摊薄每股收益$-2.77$-4.02$-4.00$-1.85$-0.47

Mirum Pharmaceuticals, Inc. MIRM